Raymond James & Associates’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-641
Closed -$9K 3898
2022
Q2
$9K Buy
+641
New +$9K ﹤0.01% 3828